ADAashis Dutta

Aashis Dutta

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aashis Dutta has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Myrica esculenta fruit extract as a nutraceutical supplement mitigating LPS-induced inflammation through COX-2 and iNOS modulation: integrated in vitro, in vivo, and docking approaches

    by Leena Das, Manas Das, Luit M. Barkalita, Probodh Borah, Ananya Chetia, Momita Rani Baro, Ratul Chakraborty, Aashis Dutta

    Myrica esculenta Buch. -Ham. ex D. Don, traditionally referred to as “Noga Tenga” in Assam and “Soh-Phi” by the Khasi tribe, holds a longstanding place in Indian medicine for antimicrobial, antidiabetic, and respiratory ailments. This study evaluates the anti-inflammatory potential of the methanolic extract of M. esculenta fruit (MEMEF) in LPS-challenged RAW 264.7 macrophages and a complementary in vivo system. Swiss albino male mice (n = 6) were pre-treated orally with MEMEF for seven days followed by a single intraperitoneal dose of LPS (3 mg/kg bw). Serum AST, ALT, ALP, NO, PGE2, and cytokines were measured, and inos and cox-2 mRNA expression was analyzed by qPCR. In vitro, RAW 264.7 cells were pre-treated with MEMEF (16.7 and 33.5 µg/ml) and stimulated with LPS (1 µg/ml) for 24 h. LC–MS analysis identified major phytoconstituents, and molecular docking examined interactions of epigallocatechin-3-gallate, resveratrol, and myricitrin with COX-2 and iNOS. MEMEF pre-treatment significantly reduced LPS-induced elevations of serum biochemical markers and inflammatory mediators, with qPCR confirming downregulation of inos and cox-2 in treated groups. In vitro, MEMEF markedly decreased NO and PGE2 production and suppressed inos and cox-2 expression in activated RAW 264.7 cells. Docking results showed strong binding of epigallocatechin-3-gallate to both target proteins, suggesting a possible contribution of these interactions to the observed anti-inflammatory effects. Overall, MEMEF exhibited anti-inflammatory activity in cellular and animal models, supporting its promise as a therapeutic candidate for inflammation-related disorders and highlighting its value as a source of nutraceutical supplement derived from a traditionally consumed functional fruit.

  • Open Access

    Preliminary Study of Ethno-medicinal Practices of the Tea Tribes in Titabor Sub-division of Jorhat District, Assam.

    by Manas Das, Aashis Dutta

    Traditional knowledge trapped amongst ethnic groups require appropriate documentation for resource conservation purpose and also invites authentic scientific validation. The study is henceforth directed towards documenting the traditional knowledge of herbal formulations utilized by tea tribes of Titabor sub-division of Jorhat district along with performing of a comparative analysis of these formulations used by the tea tribes of the entire Assam. Survey was conducted in tea garden areas of Titabor sub-division and in-depth literature exploration involving diverse articles published on ethno-pharmacology of therapeutic plants utilized by tea tribes of Assam was performed utilizing following keywords:- Medicinal plants, Herbal Formulations, Tea Tribes and Assam. Information about a total of 10 herbal formulations (5-Mono-Herbal Formulations/5-Poly-Herbal Formulations) were obtained through proper consultation from January 2022 to July 2022. Performing comparative analysis revealed that herbal formulations (91% were MHFs and 9% were PHFs) were used for treating human diseases like jaundice (20%), rhematoid arthritis (16%) and respiratory diseases (13%) with around 37% preparation in paste or powdered form while 32% correspond to liquid form or juice. Majority of them are being administered orally (78%) and topically (22%). Around 8% of these plants belong to Lamiaceae family followed by Fabaceae (7%) and Asteraceae (5%) while leaves (35%), bark/roots (10%) and whole plant (8%) were mostly used. Successful pre-clinical and clinical trials involving these formulations for treating respective disorder will lead to patenting and commercialization in turn causing benefit sharing with the community.

  • Open Access

    Therapeutic Insights and Phyto-chemical Profile of Kyllinga brevifolia Rottb: A Review

    by Manas Das, Aashis Dutta

    Kyllinga brevifolia Rottb.is a perennial herb belonging to Cyperaceae family and is in use in Paraguayan medicinal system as a refreshing beverage with major claims in possessing diuretic, digestive, sedative, tonic, anti-spasmodic and sudorific properties. Information about the herb was gathered through a structured electronic and bibliotheca exploration of different indexed and non-indexed journals and reports published on ethno-pharmacology, phyto-chemistry and traditional applications involving different pre-clinical studies (1972-2024) regarding the evaluation of the effectiveness of the plant. The plantwith long slender rhizomes, solitary smooth stem, lanceolate spikelets and radially symmetrical pollen grains is enriched with phyto-constituents like flavonoids (quercetin, vitexin), terpenoids (limonene, linalool, δ-cardinene) and steroids (β-sitostenone, β-sitosterol). Various in-vitro and in-vivo scientific evidences unfold the pleiotropic nature of the herb including anti-oxidant, anti-depressant, anti-microbial, anti-aggressive, anti-spasmodic, anxiolytic and sedative property, most of which affect the nervous system. Even some traditional Paraguayan claims in pharmacological properties received controversial scientific output requiring extrapolative experimental confirmatory evidences. However, there is lack of data regarding certain aspects like phyto-constituents responsible for exhibiting effects and accurate molecular mechanism of operation. This comprehensive review summarizes the botanical description, conventional application, phyto-chemistry, pharmacological data and toxicity study of Kyllinga brevifolia Rottb. as well as marked novel directions for further research and development to scientifically authenticate the pharmacological capability of the plant.

  • Molecular docking, dynamics simulations, and in vivo studies of gallic acid in adenine-induced chronic kidney disease: targeting KIM-1 and NGAL

    by Momita Rani Baro, Manas Das, Leena Das, Aashis Dutta

    Gallic acid (GA), a naturally occurring compound with antioxidant, anti-inflammatory, anti-apoptotic, and regenerative properties, has gained attention for its potential protective role against kidney dysfunction and diseases, though its therapeutic efficacy in this context remains underexplored. The primary objective of this study was to explore the therapeutic effects of GA in treating adenine-induced chronic kidney disease (CKD) in male Wistar rats. The study evaluated GA’s therapeutic potential against CKD, along with its pharmacokinetic and drug-likeness properties through a comprehensive analysis. It also assessed GA’s inhibitory effects on key kidney proteins, KIM-1 and NGAL, using gene expression analysis, molecular docking, and molecular dynamics simulations. The results demonstrated a range of positive effects, including significant improvement in adenine-induced kidney damage, as shown by changes in urine and serum markers, as well as oxidative stress biomarkers, following GA treatment. The study revealed that GA effectively suppresses the adenine-induced gene expression of KIM-1 and NGAL. Furthermore, GA adhered to Lipinski’s Rule of Five, and molecular docking analysis indicated strong interactions and low binding energies between GA and the target proteins KIM-1 and NGAL, further supporting its efficacy in targeting these markers. Additionally, 100 ns molecular dynamics simulations showed that gallic acid has a stronger binding affinity for NGAL than for KIM-1, with higher binding energy, stability, and stronger hydrogen bonds, suggesting that it primarily influences NGAL interactions. This study underscores gallic acid’s potential in reducing adenine-induced kidney damage and improving kidney function, with computational evidence supporting its promise as a treatment for CKD.